Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2010 1
2012 1
2014 2
2015 3
2016 4
2017 2
2018 5
2019 2
2020 1
2021 2
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for omar amer
Your search for Omar Ameir retrieved no results
[No title available]
Chan EW, Eldeeb M, Sun V, Omar A, Kapusta MA, Galic J, Chen JC. Chan EW, et al. Among authors: omar a. Ophthalmol Retina. 2019 Sep;3(9):e10. doi: 10.1016/j.oret.2019.05.019. Epub 2019 Jun 7. Ophthalmol Retina. 2019. PMID: 31511173 No abstract available.
Reply.
Patrao NV, Antao S, Egan C, Omar A, Hamilton R, Hykin PG, Sivaprasad S, Rajendram R; Moorfields Diabetic Macular Edema Study Group. Patrao NV, et al. Among authors: omar a. Am J Ophthalmol. 2017 Feb;174:176. doi: 10.1016/j.ajo.2016.10.016. Epub 2016 Nov 30. Am J Ophthalmol. 2017. PMID: 27914628 No abstract available.
Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M, Chan EW, Omar A. Eldeeb M, et al. Among authors: omar a. Optom Vis Sci. 2018 Jun;95(6):545-549. doi: 10.1097/OPX.0000000000001226. Optom Vis Sci. 2018. PMID: 29787487
Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration.
Lorés-Motta L, Riaz M, Grunin M, Corominas J, van Asten F, Pauper M, Leenders M, Richardson AJ, Muether P, Cree AJ, Griffiths HL, Pham C, Belanger MC, Meester-Smoor MA, Ali M, Heid IM, Fritsche LG, Chakravarthy U, Gale R, McKibbin M, Inglehearn CF, Schlingemann RO, Omar A, Chen J, Koenekoop RK, Fauser S, Guymer RH, Hoyng CB, de Jong EK, Lotery AJ, Mitchell P, den Hollander AI, Baird PN, Chowers I. Lorés-Motta L, et al. Among authors: omar a. JAMA Ophthalmol. 2018 Aug 1;136(8):875-884. doi: 10.1001/jamaophthalmol.2018.2019. JAMA Ophthalmol. 2018. PMID: 29852030 Free PMC article.
Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel.
Chapman AM, Schurer M, Weijers L, Omar A, Lee H, Weidenfeller AZ, Ellis C, Sonecha S, Schneider-Gold C. Chapman AM, et al. Among authors: omar a. BMC Neurol. 2021 Dec 1;21(1):467. doi: 10.1186/s12883-021-02491-3. BMC Neurol. 2021. PMID: 34852780 Free PMC article.
24 results